{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:04:43Z","timestamp":1788174283042,"version":"build-2803163510"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2435","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T21:39:12Z","timestamp":1410817152000},"page":"2153-2157","source":"Crossref","is-referenced-by-count":7,"title":["A Fatal Case of Acute Myocardial Infarction following the Improvement of Influenza A(H1N1)pdm2009-related Acute Myocarditis"],"prefix":"10.2169","volume":"53","author":[{"given":"Naoki","family":"Iwanaga","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"},{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Soda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Sasebo City General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, Nagasaki University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 45: 169-173, 2009.","DOI":"10.1016\/j.jcv.2009.06.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719, 2010.","DOI":"10.1056\/NEJMra1000449"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kodama M. Influenza myocarditis. Circ J 74: 2060-2061, 2010.","DOI":"10.1253\/circj.CJ-10-0833"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr Influenza 20: RRN1139, 2009.","DOI":"10.1371\/currents.RRN1139"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ukimura A, Izumi T, Matsumori A. Clinical Research Committee on Myocarditis Associated with the 2009 Influenza A (H1N1) Pandemic in Japan organized by the Japanese Circulation Society. Circ J 74: 2193-2199, 2010.","DOI":"10.1253\/circj.CJ-10-0452"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611-2618, 2004.","DOI":"10.1056\/NEJMoa041747"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Guan XR, Li X, Xin XM, et al. Influenza virus infection and risk of acute myocardial infarction. Inflammation 31: 266-272, 2008.","DOI":"10.1007\/s10753-008-9074-2"},{"key":"8","unstructured":"8. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9: 601-610, 2009."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Khater F, Moorman JP. Complications of influenza. South Med J 96: 740-743, 2003.","DOI":"10.1097\/01.SMJ.0000084984.13843.C0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Martin SS, Hollingsworth CL, Norfolk SG, Wolfe CR, Hollingsworth JW. Reversible cardiac dysfunction associated with pandemic 2009 influenza A (H1N1). Chest 137: 1195-1197, 2010.","DOI":"10.1378\/chest.10-0032"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130: 304-309, 2008.","DOI":"10.1016\/j.ijcard.2008.04.044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Blum A, Sclarovsky S, Rechavia E. \"Infective\" myocardial infarction. Chest 103: 1084-1086, 1993.","DOI":"10.1378\/chest.103.4.1084"},{"key":"13","unstructured":"13. Marsden PA. Inflammation and coagulation in the cardiovascular system: the contribution of influenza. Circ Res 99: 1152-1153, 2006."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Guan X, Yang W, Sun X, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 61: 591-598, 2012.","DOI":"10.1007\/s00011-012-0449-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 52: 1527-1539, 2008.","DOI":"10.1016\/j.jacc.2008.07.051"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kohno S, Kida H, Mizuguchi M, Shimada J. Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 54: 4568-4574, 2010.","DOI":"10.1128\/AAC.00474-10"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hernandez JE, Adiga R, Armstrong R, et al.: on behalf of the eIND Peramivir Investigators. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an emergency IND program in the United States. Clin Infec Dis 52: 695-706, 2011.","DOI":"10.1093\/cid\/cir001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nasu T, Ogawa D, Wada J, Makino H. Peramivir for severe influenza infection in a patient with diabetic nephropathy. Am J Respir Crit Care Med 182: 1209-1210, 2010.","DOI":"10.1164\/ajrccm.182.9.1209"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009). Circ J 75: 734-743, 2011.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"20","unstructured":"20. Kodama M, Okura Y, Hirono S, et al. A new scoring system to predict the efficacy of steroid therapy for patients with active myocarditis: a retrospective study. Jpn Circ J 62: 715-720, 1998."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kato S, Morimoto S, Hiramitsu S, et al. Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis. Heart Vessels 22: 48-51, 2007.","DOI":"10.1007\/s00380-006-0923-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/18\/53_53.2435\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T13:52:21Z","timestamp":1621432341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/18\/53_53.2435\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":21,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2435","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}